Watch our latest webinar: Who can you trust? A pharma leader’s guide to vetting AI for insights
View NowCase studies
We helped a global vaccine brand unlock years of disconnected research and turn it into a living strategic asset, giving the team a clearer brand story and greater confidence in future investment decisions.
The client had launched successfully and built solid market traction, but the next phase of growth required a clearer understanding of the vaccination journey. Years of research existed across qual, quant and analytics, but it sat across different teams and time periods. Rather than commission new research, the client wanted to connect what they already knew into a single, clearer strategic direction.
We used InsightBrain®, our AI decision engine, to unify years of existing research into a clear view of the vaccination journey. By connecting attitudinal, behavioural and market data, we uncovered tensions and gaps across studies, then used those insights to shape focused, hypothesis-led research with consumers and HCPs.
By bringing together existing learning into a single strategic view of the vaccination journey, we helped the client sharpen their narrative around the moments that mattered most. The team has continued to use the shared platform to inform messaging development and local adaptation.
Too many brands assume the answer is more research, when often answers are already sitting in fragmented internal data. The breakthrough came from using AI to surface and connect existing knowledge, then applying human judgement to turn it into strategic action.
Next Case Study
Shaping a winning competitive strategy to accelerate uptake